Trial intelligence / Profile preview

Mifepristone plus misoprostol regimens for termination of 8-16 week pregnancy

ChiCTR-TRC-11001438Phase 4Completed

Sponsor
Shanghai Institute of Planned Parenthood Research
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of mifepristone and misoprostol in pregnancy (4 arms), sponsored by Shanghai Institute of Planned Parenthood Research. Primary endpoint: Successful rate of medical abortion. Started Jul 2009; status: completed.

02

Drugs

mifepristonemisoprostol
03

Conditions

pregnancy

Beyond the preview

Go deeper on ChiCTR-TRC-11001438.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001438.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call